Page 5
Clonmel Healthcare is delighted to announce the launch of Lenalidomide Clonmel 5mg, 10mg, 15mg, 20mg, 25mg hard capsules. Lenalidomide Clonmel is indicated for the treatment of multiple myeloma,…
Servier Laboratories (Ireland) Ltd is delighted to announce that Lipertance, the combination of atorvastatin, perindopril and amlodipine1, will be available for prescription from November 2021 and is listed…
AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Active Psoriatic Arthritis AbbVie (NYSE: ABBV)…
Servier Laboratories (Ireland) Ltd is delighted to announce that Lipertance, the combination of atorvastatin, perindopril and amlodipine1, will be available for prescription from November 2021 and is listed…
Clonmel Healthcare are delighted to announce the introduction of Oyavas®, the new Bevacizumab biosimilar. Oyavas® is an anti-VEGF monoclonal antibody, indicated for the treatment of the same…
In December of last year, Ireland’s international research-based biopharmaceutical industry rolled out a new set of films, telling an impact and value story for medicines innovation as part…
Enzalutamide is now the only oral therapy approved by the European Commission to treat three distinct types of advanced prostate cancer Astellas Pharma Inc. (TSE: 4503, President and…
Infections caused by antibiotic resistant bacteria, including MRSA, are responsible for 25,000 deaths per year in the EU Research led by scientists in NUI Galway has identified a…
Clonmel Healthcare are pleased to unveil the new packaging for Caldease 15% w/w Medicated Ointment. On the market since 1986, Caldease Ointment promotes the healing of nappy rash…
You’re all caught up.
